Navigation Links
Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players
Date:11/8/2010

roteomics, Applied BioSystems, BG Medicine, Covance, Eli Lilly, Pfizer and Astra Zeneca are some of the major companies engaged in collaborative partnerships in the past three years.

• A number of market players have formed strategic alliances for the development and sharing of technology for biomarker applications in the late stage clinical trials.

• Pharmaceutical companies are focusing mainly on cancer biomarkers for use in late stage (Phase III and IV) clinical trials.

Key questions answered• How is the biomarker late stage clinical trials market segmented and what will growth be to 2014?

• What are the major technologies that have emerged such as microarrays, PCR, LC/MS and GC/MS?

• In which areas are the companies focusing while forming strategic alliances with other industrial players?

• What is the competitive landscape and what is the strategic focus of innovator companies, CROs and biomarker specialists?

• What applications are pharmaceutical companies focusing on while conducting late stage biomarker clinical trials?

Companies mentionedAbbott , Astra Zeneca , Bayer Schering Pharma , Boehringer Ingelheim , Bristol-Myers Squibb , Covance , Eisai Co. Ltd , Eli Lilly , GSK , ICON plc , Merck and Co. Inc. , Novartis , Pfizer , Roche , Sanofi-Aventis , Takeda Pharmaceuticals

Table of ContentsBiomarkers in Late Stage Clinical Trials

Executive summary 12

Market dynamics 12

Biomarker activity at leading pharma companies 13

Applications of biomarkers in clinical trials 13

Biomarker market for late stage clinical trials by tools and services 14

Company profiles 15

Chapter 1 Market dynamics 18

Summary 18

Introduction 19

Factors influencing biomarker adoption in clinical trials 22

Investment scenario for late stage clinical trials 22

Cost of clinical trials: early stage v
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Decision Biomarkers Inc Announces Formation of Scientific Advisory Board
2. Banyan Biomarkers Announces Issuance of U.S. Patent for Biomarkers for Traumatic Injury
3. Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum
4. OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimers Disease
5. iCardiac Applies Advanced Cardiac Safety Biomarkers in Clinical Study for Top Pharmaceutical Company
6. Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions
7. VisEn Launches Next-Generation Fast (Fluorescence Activatible Sensor Technology) Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo
8. Data on WaferGens SmartChip(TM) System to be Presented at 3rd Annual Rediscovering Biomarkers Conference
9. Frost & Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market
10. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
11. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 WriteResult, LLC – a ... been working with a team of researchers from Yale ... Community Farming Collaborative to provide electronic questionnaire data collection ... study, which started in May, aims to evaluate the ... weekly exposure to and participation in urban agriculture to ...
(Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ... today announced next steps for its Oral Amphotericin ... from its in vitro work involving ... iCo now plans to complete pre clinical studies ... initial Phase 1A clinical trial, utilizing approximately $700,000 ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 /PRNewswire/ ... announced today that rare disease expert John C. ... research. Dr. McKew brings more than two decades of ... the National Institutes of Health, Wyeth Research and Genetics ... will lead aTyr,s efforts to expand and translate its ...
Breaking Biology Technology:myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... Senetek PLC,(OTC Bulletin Board: SNKTY), a Life Sciences ... science of healthy aging, today,announced that shareholders have approved ... Annual General Meeting of Shareholders held on,December 16, 2008. ... pleased with the results of the voting and we ...
... In a recent customer satisfaction,survey of over 30,000 readers ... by its customers as the "Top Of Class" winner ... who,subscribe to ADVANCE chose bioMerieux over other clinical laboratory ... "reliable,instruments," and "quick response time." , ...
... Senior Director, Commercial Development;Sam Zeller appointed Senior Director, Regulatory ... Mass., Dec. 17 Microbia Precision Engineering, Inc. (Microbia) ... team and bioproduct commercialization capabilities with the appointments of ... Sam Zeller as Senior Director of Regulatory Affairs. , ...
Cached Biology Technology:Senetek PLC Announces 2008 Annual General Meeting Voting Results 2Laboratory Customers Name bioMerieux 'Top Of Class' for Microbiology 2Microbia PE Bolsters Senior Management Team; Positions Company for Commercializing Proprietary Bioproducts 2Microbia PE Bolsters Senior Management Team; Positions Company for Commercializing Proprietary Bioproducts 3
(Date:10/16/2014)... challenged conventional thinking on how the bowel lining develops ... how bowel cancer starts. , The researchers produced evidence ... the ,crypts, that are a feature of the bowel ... bowel cancer development, a controversial finding as scientists are ... 3D imaging technologies, Dr Chin Wee Tan and Professor ...
(Date:10/15/2014)... Oct. 15, 2014 Sandata Technologies, LLC, ... and community-based care, today announced it released a ... Santrax® Electronic Visit Verification™ Solution (EVV™)  for Quality ... home health company founded in 1996 and has ... The study details the challenges ...
(Date:10/15/2014)... to bacterial pneumonia in female mice to an enzyme ... are naturally more resistant to respiratory infections than males. ... increased resistance to bacterial pneumonia in female mice is ... They also show that this enzyme is ultimately activated ... , The team, lead by Professor Lester Kobzik at ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... In our zest for cleanliness, have we permanently muddied ... from Arizona State University, in collaboration with federal partners,has ... Minnesota, finding widespread evidence of the presence of active ... and rivers. These products are a billion dollar ...
... species could soon follow, according to new research. Scientists have ... team has now carried out the first experiment to prove ... Society journal Biology Letters , the study shows how ... to become extinct. The University of Exeter team believes any ...
... the U.S. Department of Energy,s Ames Laboratory are helping ... tissue structures. The new method opens up new ... for biofuels research and crop genetics. "The ... Ames Laboratory faculty scientist heading up the project, funded ...
Cached Biology News:Antimicrobials from personal care products found in statewide survey of Minnesota's rivers and lakes 2Antimicrobials from personal care products found in statewide survey of Minnesota's rivers and lakes 3Antimicrobials from personal care products found in statewide survey of Minnesota's rivers and lakes 4Study proves that 1 extinction leads to another 2Finding new research frontiers in a single cell 2Finding new research frontiers in a single cell 3
... Genomic Labeling Systems are a high-performance labeling ... DNA samples for array-based Comparative Genomic Hybridization ... labeling formats, the BioPrime Plus Array CGH ... to your genomic labeling needs. Using ...
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
Request Info...
...
Biology Products: